A draft Commission Regulation has been published and the intention is to update Annex III to Regulation (EC) No 1925/2006 on substances subject to restrictions and substances under European Community surveillance. Thanks to Neotron expertise, the aim is to support clients to put safe products in the market to guarantee food safety and human health and well-being.
“NDELA” Nitrosamine in pharma productsPosted in: Highlights, News
Pharmaceutical companies, involved in the production of finished pharmaceutical products, such as topical creams or foams, following the risk assessment envisaged by EMA guidelines, must investigate the presence of any traces of N-Nitrosodiethanolamine (NDELA) in their finished products. Learn more